Phase II study results of a replacement therapy for hereditary angioedema with subcutaneous C1‐inhibitor concentrate

By  

ALLERGY, Vol. 70, Iss. 10, 2015-10 ,pp. : 1319-1328

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-Term Prophylaxis of Hereditary Angioedema with a Pasteurized C1 Inhibitor Concentrate

By  

International Archives of Allergy and Immunology, Vol. 154, Iss. 4, 2010-10 ,pp. : 356-359

Karger

Access to resources Recommend Favorite

Pharmacokinetics of plasma‐derived C1‐esterase inhibitor after subcutaneous versus intravenous administration in subjects with mild or moderate hereditary angioedema: the PASSION study

By  

TRANSFUSION, Vol. 54, Iss. 6, 2014-06 ,pp. : 1552-1561

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hereditary Angioedema: Long-Term Treatment with One or More Injections of C1 Inhibitor Concentrate per Week

By  

International Archives of Allergy and Immunology, Vol. 154, Iss. 1, 2010-07 ,pp. : 81-88

Karger

Access to resources Recommend Favorite

Home Therapy with Plasma-Derived C1 Inhibitor: A Strategy to Improve Clinical Outcomes and Costs in Hereditary Angioedema

By  

International Archives of Allergy and Immunology, Vol. 166, Iss. 4, 2015-04 ,pp. : 259-266

Karger

Access to resources Recommend Favorite